Trial Details

COMPLETED
Basic Information
Clinical ID c1327
Identifier NCT05192863
Trial Title A Study of Vedolizumab in Adults With Crohn's Disease (CD)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions OTHER: No Intervention
Participant Information
Sponsor Takeda
City Alberta
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2023-03-20
Primary Completion Date 2025-10-31
Completion Date 2025-10-31